TR-1: Notification of major holdings

RNS Number : 5876G

Two Shields Investments PLC

18 March 2020

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer andto the FCA in

Microsoft Word format if possible)i

1a. Identity of the issuer or the	Two Shields Investments PLC
underlying issuer of existing shares to
which voting rights are attachedii:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if
appropriate)
Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights				X
Other (please specify)iii: admission of new shares
3. Details of person subject to the notification obligationiv
Name				SPREADEX LTD
City and country of registered office (if		St Albans, UK
applicable)
4. Full name of shareholder(s) (if different from 3.)v
Name
City and country of registered office (if
applicable)
5. Date on which the threshold was	17/03/2020
crossed or reachedvi:
6. Date on which issuer notified	17/03/2020
(DD/MM/YYYY):
7. Total positions of person(s) subject to the notification obligation
		% of voting		% of voting rights		Total number of
			through financial
		rights attached		Total of both in
			instruments	voting rights of
		to shares (total		% (8.A + 8.B)
			(total of 8.B 1 +	issuervii
		of 8. A)
			8.B 2)
Resulting
situation on the
date on which		5.47%				5.47%	6,477,011,131
threshold was
crossed or
reached
Position of
previous		6.30%				6.30%
notification (if
applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type of	Number of voting rightsix	% of voting rights
shares
ISIN code (if	Direct	Indirect	Direct	Indirect
(Art 9 of Directive	(Art 10 of Directive	(Art 9 of Directive	(Art 10 of Directive
possible)	2004/109/EC)	2004/109/EC)	2004/109/EC) (DTR5.1)	2004/109/EC)
	(DTR5.1)	(DTR5.2.1)		(DTR5.2.1)
GB00BYQ5L258	354,500,000		5.47%
SUBTOTAL 8. A	354,500,000	5.47%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

		Exercise/	Number of voting
Type of	Expiration	rights that may be	% of voting

Page 1 of 3

financial	datex	Conversion	acquired if the	rights
instrument		Periodxi	instrument is
			exercised/converted.

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of	Expiration	Exercise/	Physical or		Number of	% of voting
financial	Conversion	cash
datex	xii	voting rights	rights
instrument	Period	xi	settlement

SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal

entity and does not control any other undertaking(s) holding directly or indirectly an interest	X
in the (underlying) issuerxiii
Fullchain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person
or legal entityxiv (please add additional rows as necessary)
	% of voting rights	% of voting rights
	through financial	Total of both if it
	if it equals or is
Namexv	instruments if it	equals or is higher
higher than the
equals or is higher	than the notifiable
	notifiable
	than the notifiable	threshold
	threshold
	threshold

10. In case of proxy voting, please identify: Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

David Corben 01727895135

Place of	UK
completion
Date of	17/03/2020
completion

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please [e-mail] visit www.rns.com.

END

Page 2 of 3

HOLGRGDXIBBDGGI

Page 3 of 3